Sheldon Zitman, MD
Family Medicine · Cupertino
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
- California licence: Delinquent
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Zitman’s office at (408) 996-9339 to ask if they take your plan before you enroll.
California Medical Board record
Licence G37930 · Delinquent
Licence status: Delinquent · since 1978 · expires 2021-12-31 · Temple University School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Money from drug and device companies
$19 in 2021
| 2021 | 1 | 1 | None | $19 |
| 2020 | 14 | 20 | None | $399 |
| 2019 | 24 | 103 | None | $1,778 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Eliquis | $19 | 1 payment
|
See the published payment
| Pfizer | Meals · 2021-02-18 | Eliquis | $19 |
See earlier years (2020, 2019)
2020: $399
| Teva Pharmaceuticals USA | Ajovy | $51 | 2 payments
|
| Pfizer | Eucrisa | $43 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $43 | 2 payments
|
| Astellas Pharma US | Vesicare | $42 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $42 | 2 payments
|
| Lilly USA | Synjardy | $29 | 2 payments
|
| Arbor Pharmaceuticals | Edarbi | $25 | 1 payment
|
| Amgen | Aimovig | $24 | 1 payment
|
| Seqirus USA | Fluad | $19 | 1 payment
|
| Allergan | Ubrelvy | $17 | 1 payment
|
| Novo Nordisk | Ozempic | $17 | 1 payment
|
| GlaxoSmithKline | Shingrix | $17 | 1 payment
|
| AbbVie | Creon | $15 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $15 | 1 payment
|
2019: $1,778
| Teva Pharmaceuticals USA | Ajovy | $248 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $231 | 13 payments
|
| Pfizer | Eucrisa | $200 | 13 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $122 | 7 payments
|
| Allergan | Vraylar | $120 | 9 payments
|
| Mylan Specialty L.P. | Yupelri | $113 | 5 payments
|
| Merck Sharp & Dohme | Pneumovax 23 | $110 | 7 payments
|
| Sunovion Pharmaceuticals | Lonhala Magnair | $92 | 10 payments
|
| Lilly USA | Basaglar | $64 | 4 payments
|
| GlaxoSmithKline | Shingrix | $52 | 3 payments
|
| AbbVie | Creon | $45 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $44 | 3 payments
|
| Amgen | Aimovig | $40 | 2 payments
|
| Genentech USA | Xofluza | $40 | 2 payments
|
| Philips Electronics North America | Reusable Vest | $40 | 1 payment
|
| Janssen Pharmaceuticals | Invokana | $38 | 2 payments
|
| Arbor Pharmaceuticals | Edarbi | $35 | 2 payments
|
| Seqirus USA | Flucelvax Quadrivalent (Multi-Dose Vial) | $29 | 2 payments
|
| Becton Dickinson and | Bd Surepath | $24 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $23 | 1 payment
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $23 | 1 payment
|
| Amarin Pharma | Vascepa | $21 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $11 | 1 payment
|
| Sanofi Pasteur | No Product Discussed | $11 | 1 payment
|
Professional record
- NPI
- 1184722332
- Licence
- CA G37930California G37930: Delinquent · expires 2021-12-31
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 20555 Prospect Road, Cupertino, CA, 95014
- NPI first listed
- 2006-09-20
- NPI last updated
- 2011-10-18
This is when the NPI record was last certified, not a medical board exam.